- Home
- CIGI vs RVMD Comparison
CIGI vs RVMD Comparison
Compare CIGI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIGI
- RVMD
- Stock Information
- Founded
- CIGI 1972
- RVMD 2014
- Country
- CIGI Canada
- RVMD United States
- Employees
- CIGI N/A
- RVMD N/A
- Industry
- CIGI
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIGI
- RVMD Health Care
- Exchange
- CIGI Nasdaq
- RVMD Nasdaq
- Market Cap
- CIGI 8.0B
- RVMD 8.7B
- IPO Year
- CIGI N/A
- RVMD 2020
- Fundamental
- Price
- CIGI $135.45
- RVMD $44.06
- Analyst Decision
- CIGI Buy
- RVMD Strong Buy
- Analyst Count
- CIGI 6
- RVMD 12
- Target Price
- CIGI $163.08
- RVMD $64.67
- AVG Volume (30 Days)
- CIGI 95.8K
- RVMD 2.2M
- Earning Date
- CIGI 02-06-2025
- RVMD 11-06-2024
- Dividend Yield
- CIGI 0.22%
- RVMD N/A
- EPS Growth
- CIGI 586.57
- RVMD N/A
- EPS
- CIGI 3.10
- RVMD N/A
- Revenue
- CIGI $4,555,575,000.00
- RVMD $742,000.00
- Revenue This Year
- CIGI $11.69
- RVMD N/A
- Revenue Next Year
- CIGI $11.88
- RVMD $1,855.42
- P/E Ratio
- CIGI $44.35
- RVMD N/A
- Revenue Growth
- CIGI 5.40
- RVMD N/A
- 52 Week Low
- CIGI $101.01
- RVMD $25.93
- 52 Week High
- CIGI $156.96
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- CIGI 28.31
- RVMD 32.07
- Support Level
- CIGI $146.98
- RVMD $44.50
- Resistance Level
- CIGI $149.61
- RVMD $46.15
- Average True Range (ATR)
- CIGI 3.17
- RVMD 1.89
- MACD
- CIGI -1.72
- RVMD -0.58
- Stochastic Oscillator
- CIGI 6.64
- RVMD 19.95
About CIGI Colliers International Group Inc. Subordinate Voting Shares
Colliers International Group Inc is a real estate services and investment management company. The company provides commercial real estate professional services and investment management to corporate and institutional clients around the world. It's primary service lines are Outsourcing & Advisory, Investment Management, Leasing and Capital Markets. Operationally, company is organized into four distinct segments: Americas; Europe, Middle East and Africa, Asia and Australasia and Investment Management.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.